Category survey

Modelling sub-clinical vCJD infection in the UK population Investments > €500k United Kingdom Prion disease 2016    

Strain Typing of vCJD Cases Investments > €500k United Kingdom Prion disease 2016    

CJD Research and Resource Centre Investments > €500k United Kingdom Prion disease 2016    

National CJD Research and Surveillance Unit Investments > €500k United Kingdom Prion disease 2016    

The Effect of Leucodepletion on Transmission of BSE by Tranfusion of Sheep Blood Components Investments > €500k United Kingdom Prion disease 2016    

To Undertake Prospective Multisource Surveillance for all Cases of Progressive Intellectual and Neurological Deterioration Occurring in Children in the UK Investments > €500k United Kingdom Prion disease 2016    

English Longitudinal Study of Ageing (ELSA) Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

Policy Research Unit in Social Care Workforce Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

Neurology Investments > €500k United Kingdom Alzheimer’s disease & other dementias|Huntington’s disease|Parkinson’s disease & PD-related disorders 2016    

Cellular pathophysiology of prion-mediated neurodegeneration – a model for understanding protein misfolding disorders Investments > €500k United Kingdom Prion disease 2016    

Towards a unified, computationally-implemented neural network for understanding semantic cognition and its disorders. Investments > €500k United Kingdom Neurodegenerative disease in general 2016    

RNA metabolism in pathology of AOA2/ALS4 neurodegenerative disorders Investments > €500k United Kingdom Motor neurone diseases 2016    

AMPA- and GABA(A) receptor signalling and corticospinal motor neuron excitability in mouse models of ALS Investments > €500k United Kingdom Motor neurone diseases 2016    

The role of Miro and PKC signalling in axonal transport defects in amyotrophic lateral sclerosis. Investments > €500k United Kingdom Motor neurone diseases 2016    

Further defining the genetic architecture of Alzheimer’s disease Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

Adult Determinants of Late Life Depression, Cognitive Decline and Physical Functioning – The Whitehall II Ageing Study Investments > €500k United Kingdom Neurodegenerative disease in general 2016    

Funding for Cognitive Imaging Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

Dementia undetected or undiagnosed in primary care: the prevalence, causes and consequences Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

Service provision for older people who are homeless and have memory problems Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

Evaluation of specialist nursing support for carers of people with dementia Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

Understanding the outcomes of people with cognitive impairment and/or dementia admitted to the general hospital Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

Systematic reviews of interventions which target modifiable risk factors for dementia Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

Managing diabetes in people with dementia: a realist synthesis (DIaMonD) Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

Cochrane Dementia and Cognitive Improvement Group Investments > €500k United Kingdom Alzheimer’s disease & other dementias|Parkinson’s disease & PD-related disorders 2016    

Head up: The development of a novel cervical orthosis to support neck weakness due to neurological disease. Investments > €500k United Kingdom Motor neurone diseases 2016    

Supporting Excellence in End of life care in Dementia (SEED programme) Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

Achieving Quality and Effectiveness in Dementia Using Crisis Teams (AQUEDUCT) Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

An Optimized Person Centred Intervention to Improve Mental Health and Reduce Antipsychotics amongst People with Dementia in Care Homes Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

Towards an evidence-based clinical management of visual hallucinations: prevalence, prognosis, impact and pathophysiology Investments > €500k United Kingdom Alzheimer’s disease & other dementias|Parkinson’s disease & PD-related disorders 2016    

Valuing Active Life In Dementia (VALID) Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

Improving the diagnosis and management of neurodegenerative dementia of Lewy body type in the NHS (DIAMOND-Lewy) Investments > €500k United Kingdom Alzheimer’s disease & other dementias|Parkinson’s disease & PD-related disorders 2016    

EFFECTIVE HOME SUPPORT IN DEMENTIA CARE: COMPONENTS, IMPACT AND COSTS OF TERTIARY PREVENTION Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

Peri-operative Enhanced Recovery hip FracturE Care of paTiEnts with Dementia-“PERFECTED” project Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

Shared decision making in mild to moderate dementia. Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

People with Stroke and Parkinson’s disease: Home and outdoor shoes Investments > €500k United Kingdom Parkinson’s disease & PD-related disorders 2016    

Carer and patient-led development of recommendations for people with dementia returning home from hospital: understanding what is important Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

Assessment and satisfaction of services for Juvenile Huntington’s Disease and modelling alternative methods of service organisation Investments > €500k United Kingdom Huntington’s disease 2016    

Goal-oriented cognitive rehabilitation in early-stage Alzheimer’s disease: multi-centre single-blind randomised controlled trial (GREAT) Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

A multi-centre randomised controlled trial to compare the clinical and cost effectiveness of Lee Silverman Voice Treatment versus standard NHS speech and language therapy versus control in Parkinson’s disease (PD COMM) Investments > €500k United Kingdom Parkinson’s disease & PD-related…

Journeying through dementia; randomised controlled trial of clinical and cost effectiveness Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

A Randomised Controlled Trial of the Effectiveness of PDSAFE to prevent Falls among People with Parkinson’s Disease Investments > €500k United Kingdom Parkinson’s disease & PD-related disorders 2016    

Reducing pathology in Alzheimer’s Disease through Angiotensin TaRgeting – The RADAR Trial Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

Minocycline in Alzheimer’s Disease Efficacy Trial: The MADE Trial Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

Assistive Technology and Telecare to maintain Independent Living At home for people with dementia: The ATTILA Trial Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

Physical activity programmes for community dwelling people with mild to moderate dementia (DAPA – Dementia And Physical Activity) Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

HTA-SYMBAD – StudY of Mirtazapine or carBamazepine for Agitation in Dementia Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

Evaluation of the clinical and cost-effectiveness of Short-term Integrated Palliative Care Services (SIPC) to OPTimise CARE for people with advanced longterm Neurological conditions (OPTCARE Neuro) Investments > €500k United Kingdom Alzheimer’s disease & other dementias|Motor neurone diseases|Parkinson’s disease & PD-related…

Imaging cerebral neuroinflammation in acute and chronic cerebrovascular disease: a predictor of outcome and biomarker for guiding treatment Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

Dementia and Cognitive Impairment in the Prison Population of England and Wales: Identifying Individual Need and Developing a skilled, Multi-Agency Workforce to Deliver Targeted and Responsive Services Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

Is it possible to develop a complex intervention to improve the outcome of fall-related injuries in people with dementia? (DIFRID) Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016